Chatellier S, Huet H, Kenzi S, Rosenau A, Geslin P, Quentin R
Département de Microbiologie Médicale et Moléculaire, Centre National de la Recherche Scientifique, Centre Hospitalier Universitaire Bretonneau, Tours, France.
J Clin Microbiol. 1996 Nov;34(11):2741-7. doi: 10.1128/jcm.34.11.2741-2747.1996.
The genetic diversity of a collection of 54 unrelated Streptococcus agalactiae strains isolated from the cerebrospinal fluid of neonates and of 60 unrelated carrier strains was evaluated by investigating the restriction fragment length polymorphism of the rRNA gene region. Three restriction enzymes were selected for use: PstI, HindIII, and CfoI. Clustering analysis revealed two phylogenetic groups of strains with 40% divergence. Group I contained two clusters, A and B, and group II contained three clusters, C, D, and E. Strains of serotype Ia were mostly distributed in cluster A, and strains of serotype Ib were mostly distributed in cluster E. Serotype III isolates did not cluster. Nevertheless, 37 of 39 isolates belonging to cluster B were serotype III. With HindIII, two rRNA gene banding patterns characterized 38 of the 39 strains of cluster B, which represents a high-virulence group. In addition, two rRNA gene banding patterns with each enzyme and/or a pair of CfoI fragments of 905 and 990 bp identified 81% of the invasive strains. On account of the genetic homogeneity of the cerebrospinal fluid strains, ribotyping is a powerful typing method for investigation of nosocomial or epidemic invasive infections only when all three enzymes are used or when PstI and HindIII or PstI and CfoI are combined with serotyping (index of discrimination, > 0.95).
通过研究rRNA基因区域的限制性片段长度多态性,评估了从新生儿脑脊液中分离出的54株无亲缘关系的无乳链球菌菌株以及60株无亲缘关系的携带菌株的遗传多样性。选择了三种限制性内切酶用于实验:PstI、HindIII和CfoI。聚类分析显示菌株存在两个系统发育组群,差异为40%。第一组包含A和B两个簇,第二组包含C、D和E三个簇。血清型Ia的菌株大多分布在A簇,血清型Ib的菌株大多分布在E簇。血清型III的分离株没有聚类。然而,B簇中的39株分离株中有37株是血清型III。用HindIII酶切时,B簇中39株菌株中的38株具有两种rRNA基因条带模式,该簇代表高毒力组。此外,每种酶的两种rRNA基因条带模式和/或一对905和990 bp的CfoI片段可鉴定出81%的侵袭性菌株。由于脑脊液菌株的基因同质性,只有当使用所有三种酶,或PstI和HindIII或PstI和CfoI与血清分型相结合时(鉴别指数>0.95),核糖体分型才是调查医院内或流行性侵袭性感染的有力分型方法。